EPHA2 and breast cancer: Therefore, in different models, including BC and CRC cell lines, deletion of EphA2-SE impairs proliferation, migration and invasion by suppressing EphA2 downstream pathways like PI3K/Akt and WNT/β-catenin signaling [81].